BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Thursday, April 23, 2026
Home » Newsletters » BioWorld Science

BioWorld Science

March 26, 2019

View Archived Issues

Patient enrollment ongoing in phase II study of KPL-716 in subjects with prurigo nodularis

Read More

iTeos Therapeutics initiates first-in-human study of EOS-100850

Read More

KCNQ1 gene mutation tied to gingival fibromatosis and growth hormone deficiency

Read More

High-fructose corn syrup deals low blow to intestines

Read More

Keeping a tight BBB after stroke

Read More

Eukaryotic initiation factor 2B modulators discovered at Denali Therapeutics

Read More

RaQualia Pharma, XuanZhu Pharma patent sodium channel protein type 9 subunit alpha blockers

Read More

Mavupharma identifies new E-NPP 1 inhibitors

Read More

Corvus Pharmaceuticals discloses new adenosine A2A and A2B receptor antagonists

Read More

LCN2 predicts organ failure and mortality risk in surgical patients with infection

Read More

Aska Pharmaceutical discovers MPGES-1 inhibitors

Read More

Macrophages regulate metabolism via noninflammatory factors

Read More

ABCG2 and GREM2 found to be associated with response to allopurinol

Read More

New mutations in NPHP3 and NEK8 are associated with renal-hepatic-pancreatic dysplasia

Read More

FDA grants IND allowance for Aptose to initiate phase I study of CG-806

Read More

Vascepa associated with reduced total ischemic events in REDUCE-IT

Read More

Data presented from first study of phase III program of AVP-786 for agitation in Alzheimer's

Read More

Smyraf approved in Japan to treat rheumatoid arthritis

Read More

European phase III ARTEMIS study of AR-101 meets primary endpoint

Read More

Phase II trial of lurbinectedin in relapsed SCLC meets primary endpoint

Read More

Vaccibody reports phase IIa data on VB10.16 immunotherapy for CIN 2/3

Read More

Transgene and BioInvent extend multifunctional oncolytic virus collaboration

Read More

AQP5 gene polymorphism prolongs survival of patients with sepsis

Read More

Japanese MHLW approves Kymriah and related therapies Treakisym and Actemra

Read More

Knockout model highlights role of RasD2 in metabolism

Read More

Japan first to approve Skyrizi for psoriasis indications

Read More

Vyndaqel approved in Japan for transthyretin amyloid cardiomyopathy

Read More

Onoact gains approval in Japan for refractory and urgent fatal arrhythmia

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for April 23, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for April 21, 2026
  • Green arrow on blue abstract background

    Psychedelic space expanding on Trump’s EO

    BioWorld
    Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
  • Illustration of metastatic cancer

    At AACR: Epigenetic fingerprints in metastases track tumor origin

    BioWorld
    When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
  • In the clinic for April 21, 2026

    BioWorld
    Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing